Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Creams: SOP for Ensuring Homogeneity in Cream Batches – V 2.0

Posted on By

Creams: SOP for Ensuring Homogeneity in Cream Batches – V 2.0

Standard Operating Procedure for Ensuring Homogeneity in Cream Batches

Department Creams
SOP No. SOP/CRM/144/2025
Supersedes SOP/CRM/144/2022
Page No. Page 1 of 5
Issue Date 21/01/2026
Effective Date 26/01/2026
Review Date 21/01/2027

1. Purpose

The purpose of this SOP is to define the procedure for ensuring homogeneity in cream batches. Homogeneity in cream formulations ensures uniform distribution of active ingredients, excipients, and other components throughout the batch. This SOP ensures that the cream products meet quality specifications, providing consistent texture, efficacy, and safety for the end consumer.

2. Scope

This SOP applies to all cream formulations produced at the facility. It covers the process of ensuring that cream formulations are thoroughly mixed during production to maintain uniformity in ingredient distribution, both for the active ingredients and excipients.

3. Responsibilities

  • Production Team: Responsible for ensuring that the mixing process is carried out properly and that the equipment is functioning to achieve a homogeneous mixture.
  • Quality Control (QC) Team: Responsible for verifying the homogeneity of the batch through sampling and testing to confirm that the cream meets the required specifications.
  • Quality Assurance (QA) Team: Responsible for reviewing the results of homogeneity testing and ensuring compliance with
internal specifications and regulatory requirements.

4. Accountability

The QC Manager is accountable for ensuring that homogeneity testing is performed in accordance with this SOP. The Production Supervisor is responsible for ensuring that the cream formulations are uniformly mixed during production. The QA Manager ensures that the test results are reviewed and approved in compliance with GMP and regulatory standards.

5. Procedure

5.1 Pre-Test Preparation

  1. Ensure that the necessary equipment for testing homogeneity is available, including a calibrated laboratory balance, a mixing machine, and a sample collection kit.
  2. Ensure that the batch record has been reviewed to confirm that all ingredients and formulation details are correct, and to identify the appropriate testing method for homogeneity.
  3. Prepare the necessary calibration standards or reference materials if needed, and ensure that all equipment is in proper working condition before starting the production process.

5.2 Mixing Process

  1. Ensure that the cream is mixed according to the established formulation procedures, with specific attention to achieving uniform distribution of all ingredients.
  2. Monitor the mixing speed and time to ensure that it falls within the optimal range for achieving homogeneity. Typically, mixing should be conducted at a consistent speed for a specified time to ensure complete blending.
  3. Ensure that all mixing equipment (e.g., planetary mixers, homogenizers) is calibrated and functioning properly before use.

5.3 Sampling for Homogeneity Testing

  1. Collect representative samples from different areas of the batch, including the top, middle, and bottom sections, to ensure accurate representation of the entire batch.
  2. Label each sample with the batch number, sample ID, sampling date, and other relevant details to ensure traceability during testing.
  3. Ensure that the sample is taken using proper aseptic techniques to prevent contamination and preserve homogeneity.

5.4 Homogeneity Testing Procedure

  1. Weigh each sample using a calibrated laboratory balance to ensure the correct quantity for testing.
  2. Test the samples for uniformity of content, checking the concentration of active ingredients and excipients. This can be done using techniques such as HPLC, UV-Visible spectrophotometry, or other appropriate analytical methods.
  3. Perform testing for each sample in triplicate to ensure consistency and reliability of the results.
  4. Record the results of each test, including the measured concentration of each active ingredient and any deviations from the expected content, in the Homogeneity Testing Log (Annexure-1).

5.5 Interpretation of Results

  1. Compare the results of the homogeneity tests with the established specifications for the batch. The concentration of the active ingredients and excipients should be within the specified range to ensure uniformity.
  2. If the test results show that the sample is within the acceptable range, mark the test as “Pass” in the Homogeneity Testing Log (Annexure-1) and proceed with the next stage of production or release.
  3. If the test results show that the sample is outside the acceptable range, mark the test as “Fail.” Investigate the cause of the variation, which may include improper mixing, incorrect formulation, or equipment malfunction.

5.6 Post-Test Activities

  1. Record all test results, including batch number, sample ID, test date, and any corrective actions taken in the Homogeneity Testing Log (Annexure-1).
  2. If the homogeneity test fails, initiate corrective actions such as adjusting the formulation, improving mixing techniques, or reprocessing the batch to ensure homogeneity. Re-test the sample after corrective actions.
  3. Submit the test results for review and approval by the QA team to ensure compliance with internal and regulatory standards.

5.7 Documentation and Record-Keeping

  1. Ensure that all homogeneity testing records are complete, accurate, and securely stored. This includes the Homogeneity Testing Log (Annexure-1) and the Deviation Log (Annexure-2) for failed tests.
  2. Retain all records for a minimum of two years or as required by regulatory guidelines.
  3. Ensure that records are reviewed and approved by the Quality Assurance team to verify compliance with GMP standards and regulatory requirements.

6. Abbreviations

  • GMP: Good Manufacturing Practices
  • QC: Quality Control
  • QA: Quality Assurance
  • PPE: Personal Protective Equipment
  • HPLC: High-Performance Liquid Chromatography

7. Documents

  1. Annexure-1: Homogeneity Testing Log
  2. Annexure-2: Deviation Log

8. References

  • Good Manufacturing Practices (GMP) Guidelines – 21 CFR Part 211
  • International Conference on Harmonisation (ICH) Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • Pharmacopeial Monographs on Uniformity of Content and Mixing Procedures

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Homogeneity Testing Log

Batch Number Sample ID Test Date Active Ingredient Content (%) Operator
12345 S-001 21/01/2026 98.5% John Doe

Annexure-2: Deviation Log

Deviation Date Batch Number Deviation Description Corrective Action Taken Operator
21/01/2026 12345 Active ingredient content out of specification Reformulated and re-tested Jane Smith

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/03/2024 1.0 Initial Version New SOP Creation QA Head
01/03/2025 2.0 Format Revision and Updates Standardization of Document QA Head
See also  Creams: SOP for Maintenance of High-Shear Mixers - V 2.0
Creams V 2.0 Tags:Batch record documentation for creams, Change control procedures for cream manufacturing, Cleaning and sanitization SOPs in creams production, Complaint handling SOPs in creams production, Continuous improvement SOPs for cream manufacturing, Cream manufacturing process guidelines, Creams production documentation practices, Deviation handling SOPs in creams production, Employee training SOPs in creams manufacturing, Environmental monitoring SOPs in creams manufacturing, Equipment calibration SOPs for cream manufacturing, GMP compliance in creams production, Internal audit procedures in creams production, Packaging and labeling SOPs for creams, Pharmaceutical SOPs, Product quality review procedures for creams, Product release criteria SOPs for creams, Quality control SOPs for creams, ream manufacturing SOP, Regulatory requirements for cream production SOPs, Risk management SOPs in creams manufacturing, Stability testing SOPs for cream products, Standard operating procedures for skincare products, Supplier qualification SOPs for cream ingredients, Validation protocols for cream production processes

Post navigation

Previous Post: API Manufacturing: SOP for Documentation Review of IPC Checks – V 2.0
Next Post: BA-BE Studies: SOP for Creating Clinical Site Close-Out Checklist – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version